Hepatic ischemia/reperfusion injury can lead to remote lung injury by inducing oxidative stress and inflammation. this study aims to investigate whether support of liver function with a bioartificial liver can attenuate remote lung injury after extended hepatectomy.
Methods
Fourteen domestic pigs were subjected to liver ischemia for 150 minutes and 70–75% hepatectomy. Six hours after initiation of hepatic reperfusion the animals were randomly allocated to a 6-hour treatment with a bioartificial liver (group B, n=7) or observation (group C, n=7). Hemodynamic and metabolic parameters were monitored for 24 hours following reperfusion. Lung biopsies were used for histological, nitrotyrosine and mrNA analysis.
Results
Oxygenation gradually deteriorated in group C, but was not significantly impaired in group B. Histological evaluation revealed improvements in alveolar collapse, necrotized pneumonocytes and lymphocyte infiltration in group B. Nitrotyrosine content of the lung was lower in group B compared to group C (55±12 vs. 132±22 nM/mg protein, p<0.01). Lung mRNA expression of interleukin-6, Stat-3 and E-selectin also decreased in group B. Expression of transforming growth factor-α mRNA did not differ between groups.
Conclusions
Application of a bioartificial liver was associated with improvement in several parameters of post-hepatectomy lung injury. the mechanisms appear to involve reduced nitrosative stress and attenuation of the native inflammatory process in the lung.
PeraltaC, PeralesJC, BartronsR, The combination of ischemic preconditioning and liver bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion.Am J Pathol2002; 160: 2111–22.
2.
TakamatsuY, ShimadaK, YamaguchiK, KurokiS, ChijiiwaK, TanakaM.Inhibition of inducible nitric oxide synthase prevents hepatic, but not pulmonary, injury following ischemia-reperfusion of rat liver.Dig Dis Sci2006; 51: 571–9.
3.
WeinbroumAA, KlugerY, Ben AbrahamR, ShapiraI, KarchevskiE, RudickV.Lung preconditioning with N-acetyl-L-cysteine prevents reperfusion injury after liver no flow-reflow: A dose-response study.Transplantation2001; 71: 300–6.
4.
FernandezL, HerediaN, PeraltaC, Role of ischemic preconditioning and the portosystemic shunt in the prevention of liver and lung damage after rat liver transplantation.Transplantation2003; 76: 282–9.
KhaliliTM, NavarroA, TingP, Bioartificial liver treatment prolongs survival and lowers intracranial pressure in pigs with fulminant hepatic failure.Artif Organs2001; 25: 566–70.
7.
GermannPG, HäfnerD.A rat model of acute respiratory distress syndrome (ARDS).Part 1. Time dependency of histological and pathological changes. J Pharmacol Toxicol Methods1998; 40: 101–7.
8.
SamuelD, IchaiP, FerayC, Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation.Transplantation2002; 73: 257–64.
9.
DemetriouAA, BrownRS, BusuttilRW, Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.Ann Surg2004; 239: 660–70.
10.
SinghalA, NeubergerJ.Acute liver failure: Bridging to transplant or recovery – are we there yet?J Hepatol2007; 46: 557–64.
11.
JalanR, SenS, WilliamsR.Prospects for extracorporeal liver support.Gut2004; 53: 890–8.
12.
van de KerkhoveMP, HoekstraR, van GulikTM, ChamuleauRA.Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research.Biomaterials2004; 25: 1613–25.
13.
SuhKS, LiljaH, KamoharaY, Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver enriched and growth-associated transcription factors.J Surg Res1999; 85: 243–50.
14.
GalhardoMA, JúniorCQ, Riboli NavarroPG, Liver and lung late alterations following hepatic reperfusion associated to ischemic preconditioning or N-acetylcysteine.Microsurgery2007; 27: 295–9.
15.
HirschJ, NiemannCU, HansenKC, Alterations in the proteome of pulmonary alveolar type II cells in the rat after hepatic ischemia-reperfusion.Crit Care Med2008; 36: 1846–54.
16.
VanherweghemJL, DrukkerW, SchwarzA.Clinical significance of blood-device interaction in hemodialysis.A review. Int J Artif Organs1987; 10: 219–32.
17.
TsaiBM, WangM, PitcherJM, MeldrumKK, MeldrumDR.Hypoxic pulmonary vasoconstriction and pulmonary artery tissue cytokine expression are mediated by protein kinase C.Am J Physiol Lung Cell Mol Physiol2004; 287: L1215–9.
SimonA, RaiV, FanburgB, CochranB.Activation of the JAK-STAT pathway by reactive oxygen species.Am J Physiol1998; 275: C1640–52.
20.
HierholzerC, KalffJ, OmertL, Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury.Am J Physiol Lung Cell Mol Physiol1998; 275: 611–21.
21.
MüllerAM, CronenC, MüllerKM, KirkpatrickCJ.Heterogeneous expression of cell adhesion molecules by endothelial cells in ARDS.J Pathol2002; 198: 270–5.
22.
MulliganMS, MiyasakaM, WardPA.Protective effects of combined adhesion molecule blockade in models of acute lung injury.Proc Assoc Am Physicians1996; 108: 198–208.
23.
ScottéM, MassonS, LyoumiS, Cytokine gene expression in liver following minor or major hepatectomy in rat.Cytokine1997; 9: 859–67.
24.
HayashiY, SawaY, NishimuraM, FukuyamaN, OhtakeS, NakazawaH, MatsudaH.Peroxynitrite, a product between nitric oxide and superoxide anion, plays a cytotoxic role in the development of post-bypass systemic inflammatory response.Eur J Cardiothorac Surg2004; 26: 276–80.
25.
HaddadIY, PatakiG, HuP, GallianiC, BeckmanJS, MatalonS.Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury.J Clin Invest1994; 94: 2407–13.
26.
LinHI, ChouSJ, WangD, FengNH, FengE, ChenC F.Reperfusion liver injury induces down-regulation of eNOS and up-regulation of iNOS in lung tissues.Transplant Proc2006; 38: 2203–6.
27.
HallbeckAL, WalzTM, WastesonA.Interleukin-6 enhances transforming growth factor-alpha mRNA expression in macrophage-like human monocytoid (U-937-1) cells.Biosci Rep2001; 21: 325–39.
28.
TomiyaT, OgataI, FujiwaraK.Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration.Am J Pathol1998; 153: 955–61.
29.
ChesnuttA, KheradmandF, FolkessonHG, AlbertsMB, MatthayMA.Soluble transforming growth factor-a is present in the pulmonary edema fluid of patients with acute lung injury.Chest1997; 111: 652–6.
